William E. Barlow
Fred Hutchinson Cancer Research Center
295 Papers
1.8K Citations
William E. Barlow is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 77, co-authored 262 publications. Previous affiliations of William E. Barlow include Group Health Cooperative & University of Washington.
Chat about Author
Papers
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Bernard Asselain,William E. Barlow,John M. S. Bartlett,Jonas Bergh,Elizabeth Bergsten-Nordström,Judith M Bliss,Francesco Boccardo,Clare Boddington,Jan Bogaerts,Gianni Bonadonna,Rosie Bradley,Etienne Brain,Jeremy P Braybrooke,Philippe Broët,John Bryant,Julie Ann Burrett,David Cameron,Mike Clarke,Alan S. Coates,Robert E. Coleman,Raoul Charles Coombes,C Correa,J. Costantino,Jack Cuzick,David N. Danforth,Nancy E. Davidson,C Davies,Lucy Davies,Angelo Di Leo,David Dodwell,Mitch Dowsett,Fran Duane,Vaughan Evans,Marianne Ewertz,Bernard Fisher,John F. Forbes,Leslie G. Ford,Jean-Claude Gazet,Richard D. Gelber,Lucy Gettins,Luca Gianni,Michael Gnant,Jon Godwin,Aron Goldhirsch,Pamela J. Goodwin,Richard Gray,Daniel F. Hayes,Catherine Hill,James N. Ingle,Reshma Jagsi,Raimund Jakesz,Sam James,Wolfgang Janni,Hui Liu,Z Liu,Caroline Lohrisch,Sibylle Loibl,Liz MacKinnon,Andreas Makris,Eleftherios P. Mamounas,Gurdeep S. Mannu,Miguel Martín,Simone Mathoulin,Louis Mauriac,Paul McGale,Theresa McHugh,Philip Morris,Hirofumi Mukai,Larry Norton,Yasuo Ohashi,Ivo A. Olivotto,Soon Paik,Hongchao Pan,Richard Peto,Martine Piccart,Lori J. Pierce,Philip Poortmans,Trevor J. Powles,Kathy Pritchard,Joseph Ragaz,Vinod Raina,Peter M. Ravdin,Simon Read,Meredith M. Regan,John F.R. Robertson,Emiel J. Th. Rutgers,Suzy Scholl,Dennis J. Slamon,Lidija Sölkner,Joseph A. Sparano,Seth M. Steinberg,Rosemary Sutcliffe,Sandra M. Swain,Carolyn W. Taylor,Andrew Tutt,Pinuccia Valagussa,Cornelis J.H. van de Velde,Jos van der Hage,Giuseppe Viale,Gunter von Minckwitz,Yaochen Wang,Zhe Wang,Xiang Wang,Timothy J. Whelan,Nicholas Wilcken,Eric P. Winer,Norman Wolmark,William C. Wood,Milvia Zambetti,Jo Anne Zujewski +109 more
TL;DR: Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT.
Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System
Clifford A. Hudis,William E. Barlow,Joseph P. Costantino,Robert Gray,Kathleen I. Pritchard,Judith Anne W. Chapman,Joseph A. Sparano,Sally Hunsberger,Rebecca A. Enos,Richard D. Gelber,Jo Anne Zujewski +10 more
TL;DR: Standard definitions for efficacy end points and events in early-stage adjuvant breast cancer clinical trials are proposed and may be adopted to develop standard outcome definitions for use in trials involving other cancer sites.
849
Exercise Plus Behavioral Management in Patients With Alzheimer Disease: A Randomized Controlled Trial
Linda Teri,Laura E. Gibbons,Susan M. McCurry,Rebecca G. Logsdon,David M. Buchner,William E. Barlow,Walter A. Kukull,Andrea Z. LaCroix,Wayne C. McCormick,Eric B. Larson,Eric B. Larson +10 more
TL;DR: Exercise training combined with teaching caregivers behavioral management techniques improved physical health and depression in patients with Alzheimer disease.
Analysis of case-cohort designs.
TL;DR: Computation of a simple variance estimator is illustrated and model fitting techniques in SAS are discussed in an occupational exposure study of nickel refinery workers and three different weighting methods are considered.
707
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Joop P. W. van den Bergh,Kathleen I. Pritchard,KS Albain,Stewart J. Anderson,Rodrigo Arriagada,William E. Barlow,W. Bergsten-Nordström,Judith M Bliss,Francesco Boccardo,Rosie Bradley,Marc Buyse,David Cameron,Mike Clarke,M. Coates,Robert E. Coleman,C Correa,J. Costantino,Jack Cuzick,Neville Davidson,C Davies,A. Di Leo,Mitchell Dowsett,Marianne Ewertz,John F. Forbes,R. D. Gelber,R. Geyer,R. Gianni,M. Gnant,A. Goldhirsch,Richard Gray,Daniel F. Hayes,C. Hill,JN Ingle,Wolfgang Janni,Elizabeth MacKinnon,M. Martin,Paul McGale,Larry Norton,Yasuo Ohashi,Soonmyung Paik,Hongchao Pan,E. A. Perez,Richard Peto,R. Piccart,Lori J. Pierce,Vinod Raina,Peter M. Ravdin,J.F.R. Robertson,E.J.T. Rutgers,Joseph A. Sparano,Sandra M. Swain,Carolyn W. Taylor,Giuseppe Viale,G. von Minckwitz,Xiang Wang,Timothy J. Whelan,Nicholas Wilcken,Eric P. Winer,Norman Wolmark,William C. Wood +59 more
TL;DR: In this paper, the authors conducted a collaborative meta-analysis to clarify the risks and benefits of adjuvant bisphosphonate treatment in early breast cancer, and found that the reduction in bone recurrence was more definite (0.73-0.94; 2p=0.004).
676